Dr. Lingerfelt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2085 Henry Tecklenburg Dr
Charleston, SC 29414Phone+1 843-577-6957Fax+1 843-577-6523
Education & Training
- Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2006 - 2009
- Virginia Commonwealth University School of MedicineClass of 2006
Certifications & Licensure
- SC State Medical License 2012 - 2025
- GA State Medical License 2009 - 2013
- VA State Medical License 2006 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer Start of enrollment: 2021 May 10
Publications & Presentations
PubMed
- 46 citationsSafety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.Nicholas J Vogelzang, Mark R Olsen, Joshua J McFarlane, Edward Arrowsmith, Todd M Bauer
Clinical Genitourinary Cancer. 2020-12-01 - 8 citationsTime-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma.Wayne B. Harris, Chao Zhang, Yuan Liu, Dale Kesley Robertson, Mikhail Y. Akbashev
Tumour Biology. 2017-06-15 - 10 citationsNebulized lidocaine for intractable cough near the end of life.Brian M Lingerfelt, Craig Swainey, Thomas J. Smith, Patrick J. Coyne
The Journal of Supportive Oncology. 2007-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: